Piper Jaffray Increases Revenue Estimates Of Hologic For FY11 And FY12

According to Piper Jaffray, Hologic HOLX, FY11 and FY12 revenues have been revised. Piper Jaffray announced an increase in revenue estimates for FY11 from $1776.5M to $1780.5M and from $1,932.5M to $1,932.8M. PT of $26, EPS estimates, and rating of Overweight have all been maintained. Hologic closed yesterday at $18.05.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!